Literature DB >> 28918432

Reply to the letter to the editor: comment on "No superior treatment for primary osteochondral defects of the talus".

Jari Dahmen1,2,3, Kaj T A Lambers1,2,3, Mikel L Reilingh1,2,3, Christiaan J A van Bergen1,2,3,4, Sjoerd A S Stufkens1,2,3, Gino M M J Kerkhoffs5,6,7.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28918432     DOI： 10.1007/s00167-017-4715-3

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN： 0942-2056            Impact factor:   4.342


× No keyword cloud information.
  9 in total

1.  Effects of Pulsed Electromagnetic Fields on Return to Sports After Arthroscopic Debridement and Microfracture of Osteochondral Talar Defects: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.

Authors:  Mikel L Reilingh; Christiaan J A van Bergen; Rogier M Gerards; Inge C van Eekeren; Rob J de Haan; Inger N Sierevelt; Gino M M J Kerkhoffs; Rover Krips; Duncan E Meuffels; C N van Dijk; Leendert Blankevoort
Journal:  Am J Sports Med       Date:  2016-02-22       Impact factor: 6.202

2.  "One-step" bone marrow-derived cells transplantation and joint debridement for osteochondral lesions of the talus in ankle osteoarthritis: clinical and radiological outcomes at 36 months.

Authors:  Roberto Buda; Francesco Castagnini; Marco Cavallo; Laura Ramponi; Francesca Vannini; Sandro Giannini
Journal:  Arch Orthop Trauma Surg       Date:  2015-10-15       Impact factor: 3.067

3.  The connection between evidence-based medicine and shared decision making.

Authors:  Tammy C Hoffmann; Victor M Montori; Chris Del Mar
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

4.  Autologous collagen-induced chondrogenesis technique (ACIC) for the treatment of chondral lesions of the talus.

Authors:  P Volpi; C Bait; A Quaglia; A Redaelli; E Prospero; M Cervellin; D Stanco; L de Girolamo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-01-11       Impact factor: 4.342

5.  Comment on "No superior treatment for primary osteochondral defects of the talus. Dahmen J, et al. KSSTA 2017 Jun 27 PMID:28656457".

Authors:  Christian Candrian; Alberto Grassi; Giuseppe Filardo; Francesca Vannini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-09-04       Impact factor: 4.342

6.  Return to Sports After Bone Marrow-Derived Cell Transplantation for Osteochondral Lesions of the Talus.

Authors:  Francesca Vannini; Marco Cavallo; Laura Ramponi; Francesco Castagnini; Simone Massimi; Sandro Giannini; Roberto Emanuele Buda
Journal:  Cartilage       Date:  2016-04-12       Impact factor: 4.634

7.  One-step repair in talar osteochondral lesions: 4-year clinical results and t2-mapping capability in outcome prediction.

Authors:  Sandro Giannini; Roberto Buda; Milva Battaglia; Marco Cavallo; Alberto Ruffilli; Laura Ramponi; Gherardo Pagliazzi; Francesca Vannini
Journal:  Am J Sports Med       Date:  2012-12-05       Impact factor: 6.202

Review 8.  No superior treatment for primary osteochondral defects of the talus.

Authors:  Jari Dahmen; Kaj T A Lambers; Mikel L Reilingh; Christiaan J A van Bergen; Sjoerd A S Stufkens; Gino M M J Kerkhoffs
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-06-27       Impact factor: 4.342

9.  All-arthroscopic AMIC® (AT-AMIC®) technique with autologous bone graft for talar osteochondral defects: clinical and radiological results.

Authors:  Federico Giuseppe Usuelli; Riccardo D'Ambrosi; Camilla Maccario; Michele Boga; Laura de Girolamo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-09-12       Impact factor: 4.342
  9 in total
  2 in total

1.  AMIC for Focal Osteochondral Defect of the Talar Shoulder.

Authors:  Christian Götze; Christian Nieder; Hanna Felder; Filippo Migliorini
Journal:  Life (Basel)       Date:  2020-12-05

2.  Talar OsteoPeriostic grafting from the Iliac Crest (TOPIC) for large medial talar osteochondral defects : Operative technique.

Authors:  G M M J Kerkhoffs; J N Altink; S A S Stufkens; J Dahmen
Journal:  Oper Orthop Traumatol       Date:  2020-09-09       Impact factor: 1.154
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.